Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Haoeyou Raises $40 Million for its China-US Mobile Health App (in: Deals & Financings)
  HitGen to Provide Merck with Drug Leads in New Collaboration (in: Deals & Financings)
  Medical Device Maker Angiotech Acquired by China Investors (in: Deals & Financings)
  Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial (in: Trials & Approvals)
  China FDA Proposes New Rules to Speed Foreign Drug Approvals (in: Gov't & Regulatory)
  Week in Review: BGI Genomics Plans $250 Million Shenzhen IPO (in: Week in Review)
  Suzhou Ribo Lands $39 Million B Round for siRNA Portfolio (in: Deals & Financings)
  Fosun Pharma Closes $90 Million Acquisition of Sweden's Breas Medical (in: Deals & Financings)
  Kangtai Biological's Stock Price Rises 12-Fold Following Shenzhen IPO (in: Deals & Financings)
  CFDA Approves Pfizer Oral Arthritis Treatment for China Use (in: Trials & Approvals)